Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?

Susannah Franco,Margaret R. Hammerschlag
DOI: https://doi.org/10.1080/14787210.2024.2359725
2024-05-29
Expert Review of Anti-infective Therapy
Abstract:Introduction Neonatal ocular prophylaxis with 0.5% erythromycin ophthalmic ointment is mandated by law in many U.S. states despite its lack of efficacy in preventing chlamydial ophthalmia and the low incidence of gonococcal ophthalmia today. The current shortage of 0.5% erythromycin ophthalmic ointment is bringing into question what alternatives exist for neonatal ocular prophylaxis for the prevention of gonococcal ophthalmia. Providers in states with mandates are concerned with the implications of administering intramuscular ceftriaxone to every newborn. Azithromycin eye drops are being considered as an alternative.
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?